Assessment of gonadal function in boys and adolescents at the diagnosis of neoplastic disease

Journal of Pediatric Endocrinology and Metabolism

Volumn 25, Issue 5-6, 2012, Pages 453-458

  Krawczuk Rybak, Maryna ^a   Płonowski, Marcin ^a   Solarz, Elzbieta ^a   Sega Pondel, Dorota ^b   Kazanowska, Bernarda ^b   Zelazowska Rutkowska, Beata ^a   Wysocka, Jolanta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute lymphoblastic leukemia; Gonadotoxicity; Lymphomas; Solid tumors; Spermatogenesis

Indexed keywords

FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; TESTOSTERONE; HORMONE; INHIBIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; HODGKIN DISEASE; HORMONE BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALE GENITAL SYSTEM DISEASE; NONHODGKIN LYMPHOMA; PREPUBERTY; PUBERTY; SOLID TUMOR; SPERMATOGENESIS; STATISTICAL SIGNIFICANCE; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL; BLOOD; BONE TUMOR; CHILD; KIDNEY TUMOR; METABOLISM; NEOPLASM; NEPHROBLASTOMA; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SARCOMA; SOFT TISSUE TUMOR; TESTIS;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FOLLICLE STIMULATING HORMONE; HODGKIN DISEASE; HORMONES; HUMANS; INHIBINS; KIDNEY NEOPLASMS; LUTEINIZING HORMONE; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASMS; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PUBERTY; SARCOMA; SOFT TISSUE NEOPLASMS; TESTIS; TESTOSTERONE; WILMS TUMOR;

EID: 84865623331     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2011-0412     Document Type: Article

References (30)

1. Soliman H, Agresta SV. Current issues in adolescent and young adult cancer survivorship. Cancer Control 2008;15:55 - 62.
2. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, et al. Chronic disease in the childhood cancer survivor study cohort: a review of published findings. J Clin Oncol 2009;14:2339 - 55.
3. Relander T, Cavallin-Stahl E, Garwicz S, Olsson AM, Willen M. Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 2000;35:52 - 63.
4. Magelssen H, Brydøy M, FossåSD. The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Urol 2006;6:312 - 22.
5. Kiserud CE, Fosså A, Bjøro T, Holte H, Cvancarova M, et al. Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy. Br J Cancer 2009;100:455 - 63.
6. Petersen PM, Skakkebaek NE, Vistisen K, Rørth M, Giwercman A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol 1999;17:941 - 7.
7. O'Flaherty C, Vaisheva F, Hales BP, Chan P, Robaire B. Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy. Hum Reprod 2008;23:1044 - 52.
8. Kulaga Z, Litwin M, Tkaczyk M, Palczewska I, Zaja̧czkowska M, et al. Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr 2011;170:599 - 609.
9. Petersen PM, Giwercman A, Hansen SW, Berthelsen JG, Daugaard G, et al. Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol 1999;17: 173 - 9.
10. Schrader M, Muller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol 2001;15:611 - 7.
11. Soda T, Okubo K, Ichioka K, Okuno H, Kohama N, et al. Sperm cryopreservation for cancer patients: 5-year experience in a private hospital in Japan. Hinyokika Kiyo 2009;55: 9 - 13.
12. Amirjannati N, Sadeghi M, Hosseini Jadda SH, Ranjbar F, Kamali K, et al. Evaluation of semen quality in patients with malignancies referred for sperm banking before cancer treatment. Andrologia 2010;43:317 - 20.
13. Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, et al. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer 2003;97:1624 - 9.
14. Fitoussi O, Eghbali H, Tchen N, Berjon JP, Soubeyran P, et al. Semen analysis and cryoconservation before treatment in Hodgkin's disease. Ann Oncol 2000;11:679 - 84.
15. Viviani S, Ragni G, Santoro A, Perotti L, Caccamo E, et al. Testicular dysfunction in Hodgkin's disease before and after treatment. Eur J Cancer 1991;11:1389 - 92.
16. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 2001;12:1307 - 11.
17. Agarwal A, Shekarriz M, Sidhu RK, Thomas AJ Jr. Value of clinical diagnosis in predicting the quality of cryopreserved sperm from cancer patients. J Urol 1996;155:934 - 8.
18. Rofeim O, Gilbert B. Normal semen parameters in cancer patients presenting for cryopreservation before gonadotoxic therapy. Fertil Steril 2004;2:505 - 6.
19. Bergadá I, Bergadá C, Campo S. Role of inhibins in childhood and puberty. J Pediatr Endocrinol Metab 2011;14:343 - 54.
20. Andersson A-M, Juul A, Petersen H, Muller J, Groome NP, et al. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 1997;82:3976 - 81.
21. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, et al. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol (Oxf) 2002;56:215 - 21.
22. Reid H, Marsden HB. Gonadal infiltration in children with leukaemia and lymphoma. J Clin Pathol 1980;33:722 - 9.
23. Hallak J, Kolettis PN, Sekhon VS, Thomas AJ Jr, Agarwal A. Cryopreservation of sperm from patients with leukemia: is it worth the effort ? Cancer 1999;9:1973 - 8.
24. O'Donovan M. An evaluation of chromatin condensation and DNA integrity in the spermatozoa of men with cancer before and after therapy. Andrologia 2005;2 - 3:83 - 90.
25. Crofton PM, Thomson AB, Evans AE, Groome NP, Bath LE, et al. Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer ? Clin Endocrinol (Oxf) 2003;3:296 - 301.
26. Foster RS, Rubin LR, McNulty A, Bihrle R, Donohue JP. Detection of antisperm-antibodies in patients with primary testicular cancer. Int J Androl 1999;14:179 - 85.
27. Lanzafame FM, La Vignera S, Vicari E, Calogero AE. Oxidative stress and medical antioxidant treatment in male infertility. Reprod Biomed Online 2009;19:638 - 59.
28. MacDonald AA, Herbison GP, Showell M, Fafquhar CM. The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with metaanalysis. Hum Reprod Update 2010;16:293 - 311.
29. Taneli F, Ersoy B, Ozhan B, Calkan M, Yilmaz O, et al. The effect of obesity on testicular function by insulin-like 3, inhibin B, and leptin concentrations in obese adolescents according to pubertal stages. Clin Biochem 2010;43:1236 - 40.
30. Winters SJ, Wang C, Abdelrahaman E, Hadeed V, Dyky MA, et al. Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells ? J Androl 2006;27:560 - 4.